Synthesis of [S-[1-C-14]Val(7)]VALSPODAR application of (+)/(-)-[C-13,14(n)]BABS and (+)/(-)-[C-13,14(n)]DPMGBS, part 4

Citation
P. Burtscher et al., Synthesis of [S-[1-C-14]Val(7)]VALSPODAR application of (+)/(-)-[C-13,14(n)]BABS and (+)/(-)-[C-13,14(n)]DPMGBS, part 4, J LABEL C R, 43(3), 2000, pp. 205-216
Citations number
26
Categorie Soggetti
Chemistry & Analysis","Inorganic & Nuclear Chemistry
Journal title
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
ISSN journal
03624803 → ACNP
Volume
43
Issue
3
Year of publication
2000
Pages
205 - 216
Database
ISI
SICI code
0362-4803(20000315)43:3<205:SO[AO(>2.0.ZU;2-3
Abstract
VALSPODAR (2) under bar, a cyclic undecapeptide anticancer drug derived fro m natural Cyclosporin D <(10)under bar>, was labelled with carbon-14 in a n ine step synthesis. The sequence started from (-)-[1-C-14]BABS <(1a)under b ar>, a highly versatile two-carbon synthon for a broad spectrum of singly/m ultiply labelled substance classes, which after conversion to (-)-[1-C-14]D PMGBS <(1b)under bar> and subsequent alkylation with isopropyl iodide gave e.p. N-Boc-S-[1-C-14]valine (7) under bar in 46% yield. Coupling to the res pective linear decapeptide P-D(8->6), followed by cyclization and selective oxidation afforded the labelled drug substance in an overall radiochemical yield of 9%.